Paragon Genomics Introduces New CleanPlex(R) NGS Panel for Pharmacogenomics Profiling at AMP 2025

Paragon Genomics Introduces New CleanPlex(R) NGS Panel for Pharmacogenomics Profiling at AMP 2025 GlobeNewswire November 14, 2025 –Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response– –Learn More About the Paragon Genomics CleanPlex(R) NGS Panel at AMP 2025 Booth # 432– FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — […]

Ten-League International Holdings Limited Announces New Order from PSA Singapore to Expand Electrification Program Following Successful BCSS Deployment

Ten-League International Holdings Limited Announces New Order from PSA Singapore to Expand Electrification Program Following Successful BCSS Deployment GlobeNewswire November 14, 2025 SINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) — Ten-League International Holdings Limited (Nasdaq: TLIH) (the “Company” or “Ten-League”), a Singapore-based provider of turnkey project solutions, today announced its subsidiary, Ten-League Port Engineering Solutions Pte.

Saputo Inc. Announces the Renewal of its Normal Course Issuer Bid

Saputo Inc. Announces the Renewal of its Normal Course Issuer Bid GlobeNewswire November 14, 2025 MONTRÉAL, Nov. 14, 2025 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company), announced today that it has received approval from the Toronto Stock Exchange (TSX) to renew its normal course issuer bid (NCIB) to purchase up to

Flow Cytometry Services Market Envisions USD 8.39 Billion by 2034, Growing at a 9.77% CAGR

Flow Cytometry Services Market Envisions USD 8.39 Billion by 2034, Growing at a 9.77% CAGR The global flow cytometry services market size is calculated at USD 3.70 billion in 2025 and is expected to reach around USD 8.39 billion by 2034, growing at a CAGR of 9.77% for the forecasted period. GlobeNewswire November 14, 2025

Blum Holdings Inc. Reports Third Quarter 2025 Financial Results

Blum Holdings Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire November 14, 2025 DOWNEY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blum,” “Blum Holdings,” “we” or “us”), a California-based publicly traded holding company, announced its financial results for the third quarter ended September 30, 2025. Blum's third quarter

Conifex Announces Third Quarter 2025 Results

Conifex Announces Third Quarter 2025 Results GlobeNewswire November 14, 2025 VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported results for the third quarter ended September 30, 2025. EBITDA* was negative $16.6 million for the quarter compared to EBITDA of negative $3.2 million in

Kailas FUGA Women Dominate on China’s Toughest Trails

Kailas FUGA Women Dominate on China's Toughest Trails International Athletes Embrace Terrain at Tsaigu and Mount Siguniang GlobeNewswire November 14, 2025 Guangzhou, China, Nov. 14, 2025 (GLOBE NEWSWIRE) — Kailas FUGA, one of the leading trail running brands, celebrated podium wins by its elite women and FUGA Mountain Club (FMC) with leading performances in the

October Retail Sales Reveal the Impact of Headwinds Challenging Consumers, Reports Circana

October Retail Sales Reveal the Impact of Headwinds Challenging Consumers, Reports Circana Nominal revenue gains in October 2025 are up against last year's preelection declines GlobeNewswire November 14, 2025 CHICAGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — CHICAGO, Nov. 14, 2025 — U.S. consumers continue to demonstrate their resiliency and flexibility in navigating the challenges facing

LUFKIN Introduces SROD(TM) V9.2.0

LUFKIN Introduces SROD(TM) V9.2.0 Sophisticated Rod Design Software Enhanced to Generate Multiple Well Design Scenarios in Minutes GlobeNewswire November 14, 2025 MISSOURI CITY, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) — LUFKIN Industries, a pioneer in rod lift optimization solutions, products, automation and software technologies and services, today announced the launch of SROD(TM) V9.2.0. The intelligent

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs GlobeNewswire November 14, 2025 Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatment Expects to initiate CDI-988 Phase 1b norovirus challenge study in Q1 2026 Granted NIH SBIR award to advance influenza A/B replication inhibitor

Scroll to Top